JP2017501154A5 - - Google Patents

Download PDF

Info

Publication number
JP2017501154A5
JP2017501154A5 JP2016539318A JP2016539318A JP2017501154A5 JP 2017501154 A5 JP2017501154 A5 JP 2017501154A5 JP 2016539318 A JP2016539318 A JP 2016539318A JP 2016539318 A JP2016539318 A JP 2016539318A JP 2017501154 A5 JP2017501154 A5 JP 2017501154A5
Authority
JP
Japan
Prior art keywords
angiotensin
rate
catecholamine
norepinephrine
mcg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016539318A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017501154A (ja
JP6824739B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/071186 external-priority patent/WO2015095535A1/en
Publication of JP2017501154A publication Critical patent/JP2017501154A/ja
Publication of JP2017501154A5 publication Critical patent/JP2017501154A5/ja
Application granted granted Critical
Publication of JP6824739B2 publication Critical patent/JP6824739B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016539318A 2013-12-18 2014-12-18 低血圧治療のための単独または併用使用されるアンギオテンシンｉｉ Active JP6824739B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361917576P 2013-12-18 2013-12-18
US61/917,576 2013-12-18
US201461955706P 2014-03-19 2014-03-19
US61/955,706 2014-03-19
PCT/US2014/071186 WO2015095535A1 (en) 2013-12-18 2014-12-18 Angiotensin ii alone or in combination for the treatment of hypotension

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019153144A Division JP7175506B2 (ja) 2013-12-18 2019-08-23 低血圧治療のための単独または併用使用されるアンギオテンシンｉｉ

Publications (3)

Publication Number Publication Date
JP2017501154A JP2017501154A (ja) 2017-01-12
JP2017501154A5 true JP2017501154A5 (enExample) 2018-02-08
JP6824739B2 JP6824739B2 (ja) 2021-02-03

Family

ID=53367119

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2016539318A Active JP6824739B2 (ja) 2013-12-18 2014-12-18 低血圧治療のための単独または併用使用されるアンギオテンシンｉｉ
JP2019153144A Active JP7175506B2 (ja) 2013-12-18 2019-08-23 低血圧治療のための単独または併用使用されるアンギオテンシンｉｉ
JP2022113327A Withdrawn JP2022137224A (ja) 2013-12-18 2022-07-14 低血圧治療のための単独または併用使用されるアンギオテンシンｉｉ
JP2025078759A Pending JP2025114753A (ja) 2013-12-18 2025-05-09 低血圧治療のための単独または併用使用されるアンギオテンシンｉｉ

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2019153144A Active JP7175506B2 (ja) 2013-12-18 2019-08-23 低血圧治療のための単独または併用使用されるアンギオテンシンｉｉ
JP2022113327A Withdrawn JP2022137224A (ja) 2013-12-18 2022-07-14 低血圧治療のための単独または併用使用されるアンギオテンシンｉｉ
JP2025078759A Pending JP2025114753A (ja) 2013-12-18 2025-05-09 低血圧治療のための単独または併用使用されるアンギオテンシンｉｉ

Country Status (25)

Country Link
US (7) US9220745B2 (enExample)
EP (2) EP3607962B1 (enExample)
JP (4) JP6824739B2 (enExample)
KR (4) KR20230051721A (enExample)
CN (4) CN111920939A (enExample)
AU (3) AU2014364528C1 (enExample)
BR (1) BR112016013961A2 (enExample)
CA (1) CA2933601A1 (enExample)
CY (1) CY1122604T1 (enExample)
DK (2) DK3607962T3 (enExample)
EA (1) EA037823B1 (enExample)
ES (2) ES2771749T3 (enExample)
FI (1) FI3607962T3 (enExample)
HR (2) HRP20251406T1 (enExample)
HU (1) HUE047062T2 (enExample)
IL (1) IL246162B (enExample)
LT (2) LT3607962T (enExample)
MX (2) MX380968B (enExample)
NZ (1) NZ721089A (enExample)
PL (2) PL3607962T3 (enExample)
PT (2) PT3607962T (enExample)
RS (2) RS67626B1 (enExample)
SI (2) SI2986308T1 (enExample)
SM (2) SMT202000018T1 (enExample)
WO (1) WO2015095535A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9572856B2 (en) 2009-12-16 2017-02-21 The George Washington University a Congressionally Chartered Not-for-Profit Corporation Method of treating low blood pressure
LT3607962T (lt) 2013-12-18 2026-01-12 The George Washington University, A Congressionally Chartered Not-For-Profit Corporation Vien tik angiotenzinas ii arba derinyje, skirtas hipotenzijos gydymui
TWI754225B (zh) * 2014-07-08 2022-02-01 美商拉荷亞製藥公司 治療低血壓之方法
US9919022B2 (en) 2015-03-20 2018-03-20 Arthur J. ATKINSON, JR. Use of angiotensin II (AII) receptor agonists to prevent or reduce hemodialysis-associated skeletal muscle cramps
BR112018013852A2 (pt) * 2016-01-07 2018-12-18 La Jolla Pharmaceutical Company métodos de administração de vasopressores
BR112018013847A2 (pt) * 2016-01-07 2018-12-18 La Jolla Pharma Co métodos para administrar a angiotensina ii
US11583568B2 (en) 2017-04-14 2023-02-21 La Jolla Pharma, Llc Methods for administering angiotensin II
US20190183962A1 (en) * 2017-12-15 2019-06-20 La Jolla Pharma, Llc Angiotensin compositions and methods related thereto
US20250366467A1 (en) * 2022-06-15 2025-12-04 Virginia Commonwealth University Methods for fluid resuscitation of an organ donor
WO2024129057A1 (en) * 2022-12-12 2024-06-20 Proletariat Therapeutics, Inc. Methods of treating cardiac injury

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU181008B (en) 1980-01-18 1983-05-30 Richter Gedeon Vegyeszet Process for producing angiotenzin-ii analogues of antagonistic activity containing sarcosyl-group at the 1-positon,and an alpha-hydroxy-carboxylic acid at the 8-position
US5216025A (en) * 1989-09-13 1993-06-01 Board Of Regents, The University Of Texas System Nitric oxide synthesis inhibitors for potentiating the action of pressor agents in certain hypotensive patients
US5444067A (en) 1993-08-30 1995-08-22 Merck & Co., Inc. Pharmaceutical treatment methods using angiotensin II receptor agonists bearing a thiophene moiety
WO2002098906A1 (en) 2001-06-04 2002-12-12 Human Genome Sciences, Inc. Methods and compositions for modulating ace-2 activity
US7115266B2 (en) 2001-10-05 2006-10-03 Cytos Biotechnology Ag Angiotensin peptide-carrier conjugates and uses thereof
US7785566B2 (en) 2003-11-06 2010-08-31 Ge Healthcare, Inc. Pharmaceutical compounds
NO20034952D0 (no) 2003-11-06 2003-11-06 Amersham Health As Farmasöytiske forbindelser
FR2880807B1 (fr) * 2005-01-19 2007-04-13 Aguettant Sa Lab Composition pharmaceutique injectable
WO2007040636A1 (en) 2005-09-29 2007-04-12 Fibrogen, Inc. Methods for reducing blood pressure
EP1971358A4 (en) * 2005-12-30 2010-05-26 Florey Howard Inst Methods of Treatment
US20070293552A1 (en) 2006-06-15 2007-12-20 Gorczynski Richard J Antihypertensive therapy method
WO2008130217A1 (en) * 2006-08-08 2008-10-30 Applied Nanosystems B.V. Cyclic angiotensin analogs
CN101795675A (zh) 2006-11-17 2010-08-04 达沃尔泰拉公司 使用具有Eudragit包衣的Zn/果胶珠粒进行的结肠递送
WO2009009907A1 (en) * 2007-07-18 2009-01-22 The University Of British Columbia Use of vasopressin-receptor agonists for the treatment of septic shock
EP2161030A1 (en) * 2008-09-09 2010-03-10 Rijksuniversiteit te Groningen Oxytocin formulations and uses thereof
MX2011005672A (es) 2008-11-28 2011-06-20 Abbott Lab Composiciones de anticuerpo estables y metodos para estabilizar a las mismas.
US9572856B2 (en) * 2009-12-16 2017-02-21 The George Washington University a Congressionally Chartered Not-for-Profit Corporation Method of treating low blood pressure
FR2959414B1 (fr) * 2010-04-30 2016-01-08 Luc Quintin Combinaison de molecules aux fins de traitement d'hypotension survenant au cours du choc septique, cardiogenique, ou anaphylactique refractaire, ou hemorragique terminal, apres correction de la volemie et de l'etat de mal asthmatique refractaire
AU2011279144A1 (en) 2010-07-14 2013-01-24 Cumberland Emerging Technologies, Inc Methods of treating hepatorenal syndrome and hepatic encephalopathy with thromboxane-A2 receptor antagonists
AU2014256944B2 (en) 2013-04-26 2019-06-27 La Jolla Pharma, Llc Compositions and methods for treating renal failure
LT3607962T (lt) 2013-12-18 2026-01-12 The George Washington University, A Congressionally Chartered Not-For-Profit Corporation Vien tik angiotenzinas ii arba derinyje, skirtas hipotenzijos gydymui
US20150286797A1 (en) 2014-04-02 2015-10-08 David R. Ratto System and method for administering medication
TWI754225B (zh) 2014-07-08 2022-02-01 美商拉荷亞製藥公司 治療低血壓之方法
BR112018013852A2 (pt) 2016-01-07 2018-12-18 La Jolla Pharmaceutical Company métodos de administração de vasopressores
BR112018013847A2 (pt) 2016-01-07 2018-12-18 La Jolla Pharma Co métodos para administrar a angiotensina ii
US11583568B2 (en) 2017-04-14 2023-02-21 La Jolla Pharma, Llc Methods for administering angiotensin II
US20190183962A1 (en) 2017-12-15 2019-06-20 La Jolla Pharma, Llc Angiotensin compositions and methods related thereto

Similar Documents

Publication Publication Date Title
EP4233861A3 (en) Compositions for treatment of essential tremor
JP2022009125A5 (enExample)
RU2015134581A (ru) Доноры нитроксила с улучшенным терапевтическим индексом
NZ598534A (en) Dosage regimen of an s1p receptor modulator
MX2014004548A (es) Metodos para tratar pacientes pediatricos usando dexmedetomidina.
RU2014141893A (ru) Применение производной пиразола в лечении острых приступов хронической обструктивной болезни легких
PH12015502465A1 (en) Use of landiolol hydrochloride in the long-term treatment of tachyarrhythmias
PH12016501357A1 (en) Pharmaceutical preparation containing pyridylamino acetic acid compound
JP2018526460A5 (enExample)
JP2020172520A (ja) 腹水の治療
JP2017519799A5 (enExample)
EP4700016A3 (en) Pharmaceutical agent for treating amyotrophic lateral sclerosis or suppressing disease progress thereof
JP2015532293A5 (ja) 糖尿病患者における心不全の治療用組成物
HRP20200009T1 (hr) Angiotenzin ii u kombinaciji za liječenje hipotenzije
RU2016103098A (ru) Способ предотвращения и/или лечения хронической травматической энцефалопатии - ii
JP2016510040A5 (enExample)
JP2019535830A5 (enExample)
JP2015512923A5 (enExample)
RU2012116226A (ru) Бронхолитическое средство на основе простагландина
NZ708511A (en) Methods for controlling blood pressure and reducing dyspnea in heart failure
JP2015535258A5 (enExample)
JP2016503406A5 (enExample)
JP2016510738A5 (enExample)
RU2015133365A (ru) Альфа-2 адренергический агонист для лечения внутриглазного давления и заболеваний глаз путем введения в стекловидное тело и внутрикамерно
RU2013148539A (ru) Алиспоривир для лечения инфекции вируса гепатита с